Depo-Provera Lawsuit & Risk of Brain Tumors

How the Depo-Provera Shot Could Put Your Brain at Risk

If you’ve been using the Depo-Provera birth control shot and were later diagnosed with a brain tumor like meningioma, you’re not alone-and you may have legal options. Depo-Provera lawsuits are gaining momentum across the country, based on scientific studies linking long-term use of the hormone medroxyprogesterone acetate to an increased risk of developing intracranial meningiomas. This isn’t just a statistical footnote. For some women, this risk has become a harsh and life-altering reality.

Injectable birth control is supposed to offer freedom and control over reproductive health. But what happens when a product marketed as safe causes a brain tumor years later? For some patients, symptoms like memory loss, chronic headaches, or even vision problems were the first signs of a growing tumor. The culprit? A contraceptive they trusted. If you’re in this position, understanding your rights could be the first step toward justice.

In this article, we’ll break down what we know about the link between Depo-Provera and brain tumors, explore the biological mechanisms behind the risk, and explain how you might qualify to join an ongoing lawsuit against Pfizer, the drug’s manufacturer. Our team at Alonso Krangle, LLP is actively investigating these cases and is here to help if you’ve been affected.

Scientific Evidence Linking Depo-Provera to Meningioma

Recent studies have raised serious concerns about a possible connection between Depo-Provera and meningiomas-a type of tumor that forms on the membranes covering the brain and spinal cord. Although typically benign, these tumors can still cause debilitating neurological issues depending on their size and location.

According to a 2024 study in The BMJ, women who used Depo-Provera had a 5.6 times higher risk of developing an intracranial meningioma compared to those who didn’t. The risk was significantly higher among women who used the shot for more than a year. Another study evaluating over 117,000 cases found a 53% increased likelihood of developing meningiomas among those exposed to medroxyprogesterone acetate-the active ingredient in Depo-Provera.

Regulatory agencies in Europe have responded by adding warning labels to progestogen-based contraceptives. Meanwhile, similar updates have been delayed in the U.S., leaving many American patients in the dark about the risks they were facing. This delay is now a focal point in multiple lawsuits.

• Long-term Depo-Provera use has been flagged as a risk factor
• European regulators have taken action, while U.S. labels remain outdated
• Multiple lawsuits allege Pfizer failed to provide proper warnings

How Synthetic Hormones May Fuel Tumor Growth

So how exactly could a birth control shot cause a tumor in the brain? It comes down to how medroxyprogesterone acetate (MPA), the synthetic hormone in Depo-Provera, interacts with cells. MPA mimics the natural hormone progesterone, binding to receptors throughout the body-including those in the brain’s protective layers, known as the meninges.

This hormonal activity can disrupt the cell cycle, promoting abnormal cell growth. Meningiomas, in particular, are known to express progesterone receptors. That means they can grow faster when exposed to synthetic progestins like MPA over a long period. Essentially, the drug may act as fuel for preexisting or dormant tumor cells.

Biological mechanisms involved include:

• MPA binding to progesterone receptors in the meninges
• Stimulation of uncontrolled cell division and reduced cell death
• Altered gene expression promoting tumor formation

It’s important to understand that the risk isn’t the same for everyone. Women with genetic predispositions, prior hormone exposure, or existing abnormalities in brain tissue may face a heightened risk.

Who’s Most at Risk After Taking Depo-Provera?

While no one can predict with certainty who will develop a meningioma, some patterns have emerged in the growing body of medical literature and legal cases. Understanding these risk factors can help patients and their doctors make more informed decisions.

• Women over 35, particularly with long-term use (12+ months)
• People with a history of hormone-sensitive tumors or family history of brain tumors
• Patients using high-dose or extended regimens of progestins

Symptoms of a meningioma are often mistaken for less serious conditions at first. These may include frequent headaches, personality changes, visual disturbances, or memory issues. That’s why many diagnoses come late-sometimes years after the Depo-Provera use began.

If you’re experiencing symptoms and have a history of Depo-Provera injections, it’s essential to talk to your doctor about the possibility of a hormone-related tumor and get the necessary imaging tests.

Recent Lawsuits and the Push for Accountability

The legal battle over Depo-Provera is heating up. As of early 2025, more than 20 lawsuits have been consolidated into multidistrict litigation (MDL) in the Northern District of Florida. Plaintiffs claim that Pfizer knew about the risks of brain tumors for years but failed to adequately warn patients or doctors.

Some of the allegations include:

• Failure to update U.S. labels despite known risks in Europe
• Negligent design and failure to test for long-term effects
• Concealing evidence of adverse events from regulators

Many of the lawsuits involve women who suffered severe medical consequences-such as invasive brain surgeries, radiation treatments, and long-term cognitive impairments-after years of Depo-Provera use. These claims seek compensation not only for medical bills, but also for lost wages, pain and suffering, and future care costs.

Eligibility to Join a Depo-Provera Brain Tumor Lawsuit

Wondering whether you or a loved one qualifies to file a lawsuit? Several key factors determine eligibility:

• You received four or more consecutive Depo-Provera or Depo-SubQ injections
• You were diagnosed with a brain tumor (especially meningioma) after using the drug
• Your diagnosis came within a reasonable time frame following prolonged use

Even if you aren’t sure how long you used the injection or whether your tumor was related, it’s worth discussing your case with our attorneys. We can help review your medical records, timelines, and eligibility at no cost to you.

Don’t delay-there are time limits (statutes of limitation) for filing a claim, and waiting too long could impact your ability to recover compensation.

How Our Attorneys Can Help If You’ve Been Harmed

If you’ve been diagnosed with a meningioma or another brain tumor after using Depo-Provera, our team at Alonso Krangle, LLP can guide you through the legal process. We’ll evaluate your case thoroughly, gather evidence, and fight to hold the responsible parties accountable. Our goal is to secure financial recovery for:

• Past and future medical expenses
• Lost income and reduced earning capacity
• Emotional trauma, mental anguish, and pain and suffering

We work on a contingency fee basis, which means you don’t pay unless we recover compensation for you. You’ll never have to worry about upfront legal costs. We know how overwhelming it can be to face a diagnosis like this-especially when it could have been prevented. Let us handle the legal fight so you can focus on your health and recovery.

Call Us Now to Discuss Your Depo-Provera Lawsuit

If you or a loved one developed a brain tumor after using Depo-Provera, you deserve answers-and you may be entitled to financial compensation. Our attorneys at Alonso Krangle, LLP are actively pursuing these cases and want to help you hold the drug manufacturers accountable for failing to warn of serious health risks.

Contact us today at 800-403-6191 or fill out our confidential form to schedule a free consultation. We’re here to listen to your story, explain your legal rights, and fight for the justice you deserve.